Bioanalysis and Laboratory Testing — Pharmaron

At Pharmaron, we approach bioanalysis and laboratory testing as a decision-focused engagement, not a disconnected list of tasks. Before work begins, we clarify the scientific or operational question, the materials and information already available, the constraints that could affect execution, and the evidence your team needs at the end. That alignment lets us build a practical scope for bioanalysis and laboratory testing while keeping the work connected to the broader program.

Our bioanalysis and laboratory testing capabilities

We offer laboratory services across drug discovery and development, including bioanalysis, DMPK, safety assessment, and specialized testing. Programs can be scoped as standalone assays or coordinated workstreams, depending on the development question. The service supports teams seeking a contract laboratory partner that can connect analytical results with broader discovery, preclinical, or clinical development activities. Testing requirements should be defined by modality, sample matrix, assay purpose, regulatory use, method status, turnaround needs, and data format. we can recommend the appropriate laboratory group and study design. Contact our team with the compound or therapeutic modality, required test, sample availability, and development milestone. This work sits within our Bioanalytical Services, Laboratory Services capabilities and is coordinated with the wider program context when the scope requires it.

• Bioanalysis of small molecules, biologics, and cell and gene therapy products
• Specialized in vitro systems and other laboratory technologies

How we shape the scope

During scoping, we work through the objective, acceptance criteria, dependencies, and potential decision points in plain language. We also identify assumptions that need to be tested before they become schedule or budget problems. The resulting plan defines responsibilities on both sides, shows where reviews will occur, and makes clear how changes in inputs or findings will be handled. This creates a shared operating picture without locking the project into details that should remain flexible.

Working with Pharmaron

We work as an extension of the program team while maintaining clear ownership of actions and decisions. Regular reviews cover completed work, near-term priorities, risks, and information needed from either side. If new evidence changes the best route, we explain the reason, the available alternatives, and the effect on deliverables or timing. The goal is a transparent engagement in which technical detail supports progress instead of obscuring it.

Deliverables built for the next decision

A deliverable is only useful if its structure matches the decision it supports. We therefore align early on content, format, traceability, and the expected level of interpretation. The completed package reflects the activities actually performed and separates results from recommendations where that distinction matters. We walk the team through key findings and open items, making it easier to carry the work into the next experiment, study activity, development stage, or internal governance review.

Planning your bioanalysis and laboratory testing project with Pharmaron

A productive first discussion about bioanalysis and laboratory testing usually includes the question to be answered, current program context, available materials or data, target timing, and required outputs. With that foundation, we can identify gaps, explain practical options, and shape a proposal that clearly states activities, inputs, responsibilities, milestones, deliverables, assumptions, and the factors most likely to change scope.